Abstract:The calcium-sensing receptor (CaSR) is responsible for sustaining a stable blood calcium concentration. Consequently, genetic and acquired changes in this G protein-coupled receptor can give rise to various calcium homeostasis disorders. Synthetic positive allosteric modulators targeting CaSR are currently used to treat hypercalcemia, but their usage is highly limited due to the high risk of severe hypocalcemia and gastrointestinal intolerance. In this study, we aimed to generate pharmacologically active CaSR-specific nanobodies that could be employed as a new generation of pharmacological tools to investigate the receptor function and potentially serve as a new drug modality for effective treatment of CaSR-related disorders. Nanobodies were generated by immunization of a llama with CHO cells recombinantly overexpressing a myc-epitope-tagged human CaSR. Following construction of a phage display library representing the repertoire of nanobody genes, nanobodies binding to the CaSR were isolated by FACS of whole HEK293 cells recombinantly overexpressing HA-epitope-tagged human CaSR. Based on sequence comparison, 37 nanobodies from 25 different sequence families were purified and subsequent characterized in vitro for modulation of CaSR signaling. The nanobodies were screened for agonist, as well as positive and negative allosteric modulators activity in in vitro cellular assays downstream of CaSR activation. We identified eight pharmacologically active nanobodies acting as positive allosteric modulators that could be divided into five main families based on their sequence identity. The most potent nanobody binding to the extracellular domain of CaSR was slightly more potent than the reference small molecule PAM NPS R-568. This study describes the discovery and pharmacological characterization of nanobodies acting as potent CaSR positive allosteric modulators. These nanobodies are a new class of pharmacological research tools for the CaSR, which potentially can be developed into new therapeutics in the treatment of CaSR-related disorders.

Structural characterization of two nanobodies targeting the ligand-binding pocket of human Arc

A Nanobody-Based Proximity Ligation Assay Detects Constitutive and Stimulus-Regulated Native Arc/Arg3.1 Oligomers in Hippocampal Neuronal Dendrites

Characterization of a nanobody-epitope tag interaction and its application for receptor engineering

Structural diversity of Arc oligomers within the excitatory synapse

Visualizing Arc protein dynamics and localization in the mammalian brain using AAV-mediated in situ gene labeling

Analysis of Arc/Arg3.1 Oligomerization In Vitro and in Living Cells

The Neuroplasticity-Associated Arc Gene is a Direct Transcriptional Target of Early Growth Response (egr) Transcription Factors

Mimicking Protein Kinase C Phosphorylation Inhibits Arc/Arg3.1 Palmitoylation and Its Interaction with Nucleic Acids

Arc/Arg3.1 binds the nuclear polyadenylate-binding protein RRM and regulates neuronal activity-dependent formation of nuclear speckles

Arc in synaptic plasticity: from gene to behavior

Structure of a nanobody-stabilized active state of the β2 adrenoceptor

Arc self‐association and formation of virus‐like capsids are mediated by an N‐terminal helical coil motif

Discovery and pharmacological characterization of nanobodies acting as potent positive allosteric modulators of the calcium-sensing receptor

Arc/Arg3.1 function in long‐term synaptic plasticity: Emerging mechanisms and unresolved issues

The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes

A Conformation-specific Nanobody Targeting the NMN-activated State of SARM1

Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist

Nanobodies against the myelin enzyme CNPase as tools for structural and functional studies

Arc ubiquitination regulates endoplasmic reticulum-mediated Ca2+ release and CaMKII signaling

Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid